Skip to main content

Advertisement

SpringerLink
Log in

Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

Background

Creutzfeldt-Jacob disease (CJD) is a fatal neuro-degenerative disease, characterized by rapid and intense deterioration, mainly cognitive, leading to death. The typical onset of the disease is around the age of 67.

Purpose

To characterize the demographic and clinical features of the population of CJD patients with late-onset disease.

Methods

In this retrospective study, the Israeli national database of prion diseases was screened for CJD patients with disease age of onset > 80 years between 1960 and 2016. Patient’s demographic and clinical data were collected including sex, type of disease (sporadic/ genetic), clinical presentation, lab results including tau protein level, imaging, and EEG characteristics. Then, the clinical and demographic data of patients with late onset (> 80 years) (L) and patients with usual age of onset (< 80 years) (U) were compared.

Results

The study included 728 patients, 23 patients (3.3%) with late-onset disease (82.2.4±4 years, range 80–88) and 705 with usual disease onset (61.31 ± 9.47 years, range 34–80). Sporadic CJD was more common in the late-onset group (18/23 patients (78.2%) (L) vs. 256/705 patients (36.3%) (U)) (p = 0.0001, chi-square test). Classical EEG finding of periodic sharp wave activity were seen more often in the late-onset patients (55% (L) vs. 32.5% (U)) (p = 0.05, chi-square test). The rest of the demographic and clinical features were similar in both groups.

Conclusion

Late- and usual-onset diseases are similar in most of demographic and clinical features suggesting a common disease type with normal distribution of age of onset.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Millhauser GL (2004) Copper binding in the prion protein. Acc Chem Res 37:79–85

    Article  CAS  Google Scholar 

  2. Bremer J, Baumann F, Tiberi C et al (2010) Axonal prion protein is required for peripheral myelin maintenance. Nat Neurosci 13:310–318

    Article  CAS  Google Scholar 

  3. Wulf MA, Senatore A, Aguzzi A (2017) The biological function of the cellular prion protein: an update. BMC Biol 15(1):34

    Article  Google Scholar 

  4. Eggenberger E (2007) Prion disease. Neurol Clin 25:833–42.viii

    Article  Google Scholar 

  5. Knight RS, Will RG (2004) Prion diseases. J Neurol Neurosurg Psychiatry 75:i36–i42

    Article  Google Scholar 

  6. Goldfarb LG, Korczyn AD, Brown P, Chapman J, Gajdusek DC (1990) Mutation in codon 200 of scrapie amyloid precursor gene linked to Creutzfeldt-Jakob disease in Sephardic Jews of Libyan and non-Libyan origin. Lancet 336:637–638

    Article  CAS  Google Scholar 

  7. Hsiao K, Meiner Z, Kahana E et al (1991) Mutation of the prion protein in Libyan Jews with Creutzfeldt-Jakob disease. N Engl J Med 324:1091–1097

    Article  CAS  Google Scholar 

  8. Korczyn AD (1991) Creutzfeldt-Jakob disease among Libyan Jews. Eur J Epidemiol 7:490–493

    Article  CAS  Google Scholar 

  9. Cali I, Cohen ML, Haik S et al (2018) Iatrogenic Creutzfeldt-Jakob disease with amyloid-β pathology: an international study. Acta Neuropathol Commun 6(1):5

    Article  Google Scholar 

  10. Croes EA, van Duijn CM (2003) Variant Creutzfeldt-Jakob disease. Eur J Epidemiol 18:473–477

    Article  Google Scholar 

  11. Lundberg PO (1998) Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 65:836–841

    Article  CAS  Google Scholar 

  12. Sun Y, Fan LY, Huang CT et al (2021) Prognostic Features of Sporadic Creutzfeldt-Jakob Disease: an analysis of Taiwan’s Nationwide Surveillance. J Am Med Dir Assoc. 4:S1525-8610(21)00736–2. https://doi.org/10.1016/j.jamda.2021.08.010

    Article  Google Scholar 

  13. Gambetti P, Kong Q, Zou W, Parchi P, Chen SG (2003) Sporadic and familial CJD: classification and characterisation. Br Med Bull 66:213–239

    Article  CAS  Google Scholar 

  14. Minikel E, Vallabh S, Orseth M et al (2019) Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology 93(2):e125–e134

    Article  CAS  Google Scholar 

  15. Knight R (2002) Epidemiology of variant CJD. Dev Biol (Basel) 108:87–92

    CAS  Google Scholar 

  16. Corato M, Cereda C, Cova E, Ferrarese C, Ceroni M (2006) Young-onset CJD: age and disease phenotype in variant and sporadic forms. Funct Neurol 21:211–215

    PubMed  Google Scholar 

  17. Boesenberg C, Schulz-Schaeffer WJ, Meissner B et al (2005) Clinical course in young patients with sporadic Creutzfeldt-Jakob disease. Ann Neurol 58:533–543

    Article  Google Scholar 

  18. WHO (1998) Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of the WHO consultation. In: World health organization: emerging and other communicable diseases, surveillance and control, Geneva, pp 9–11

  19. Hansen HC, Zschocke S, Sturenburg HJ, Kunze K (1998) Clinical changes and EEG patterns preceding the onset of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Acta Neurol Scand 97:99–106

    Article  CAS  Google Scholar 

  20. Caobelli F, Cobelli M, Pizzocaro C, Pavia M, Magnaldi S, Guerra UP (2015) The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literature. J Neuroimaging. 25:2–13

    Article  Google Scholar 

  21. Nozaki I, Hamaguchi T, Sanjo N et al (2010) Prospective 10-year surveillance of human prion diseases in Japan. Brain 133:3043–3057

    Article  Google Scholar 

  22. Appel SA, Chapman J, Kahana E et al (2010) Rapidly progressive Creutzfeldt-Jakob disease in patients with Familial Mediterranean Fever. Eur J Neurol 17:861–865

    Article  CAS  Google Scholar 

Download references

Funding

The work was partially supported by the National Institute of Health (NIH) Grant #NS043488.

Author information

Authors and Affiliations

  1. Department of Neurology, Barzilai University Medical Center, 2 Hahistadrut St., 7830604, Ashkelon, Israel

    Iliya Trachtenbroit, Zeev Nitsan, Esther Kahana & Shmuel Appel

  2. Department of Neurology, Assaf Harofeh Medical Center, Zerifin, Israel

    Oren S. Cohen

  3. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel

    Oren S. Cohen & Joab Chapman

  4. Department of Neurology, The Sagol Neuroscience Center, Chaim Sheba Medical Center, Ramat Gan, Israel

    Joab Chapman

  5. Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassa Hebrew University Medical Center, Jerusalem, Israel

    Hanna Rosenmann

  6. Faculty of Health Sciences, Ben Gurion University of the Negev, Beer-Sheva, Israel

    Zeev Nitsan, Esther Kahana & Shmuel Appel

Authors
  1. Iliya Trachtenbroit
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oren S. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Joab Chapman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanna Rosenmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zeev Nitsan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Esther Kahana
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Shmuel Appel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shmuel Appel.

Ethics declarations

Ethical approval

None.

Conflict of interest

The authors declare no competing interests.

Informed consent

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Trachtenbroit, I., Cohen, O.S., Chapman, J. et al. Epidemiological and clinical characteristics of patients with late-onset Creutzfeldt-Jakob disease. Neurol Sci 43, 4275–4279 (2022). https://doi.org/10.1007/s10072-022-05929-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-022-05929-9

Keywords

Search

Navigation